| Structure and action of the binary C2 toxin from Clostridium botulinum C Schleberger, H Hochmann, H Barth, K Aktories, GE Schulz Journal of molecular biology 364 (4), 705-715, 2006 | 149 | 2006 |
| Binding structure of elastase inhibitor scyptolin A U Matern, C Schleberger, S Jelakovic, J Weckesser, GE Schulz Chemistry & biology 10 (10), 997-1001, 2003 | 70 | 2003 |
| Outer membrane permeability: Antimicrobials and diverse nutrients bypass porins in Pseudomonas aeruginosa J Ude, V Tripathi, JM Buyck, S Söderholm, O Cunrath, J Fanous, B Claudi, ... Proceedings of the National Academy of Sciences 118 (31), e2107644118, 2021 | 67 | 2021 |
| High-resolution crystal structure of the snake venom metalloproteinase BaP1 complexed with a peptidomimetic: insight into inhibitor binding T Lingott, C Schleberger, JM Gutierrez, I Merfort Biochemistry 48 (26), 6166-6174, 2009 | 67 | 2009 |
| Seed-based IntaRNA prediction combined with GFP-reporter system identifies mRNA targets of the small RNA Yfr1 AS Richter, C Schleberger, R Backofen, C Steglich Bioinformatics 26 (1), 1-5, 2010 | 62 | 2010 |
| Catechol siderophores repress the pyochelin pathway and activate the enterobactin pathway in Pseudomonas aeruginosa: an opportunity for siderophore … V Gasser, E Baco, O Cunrath, PS August, Q Perraud, N Zill, ... Environmental microbiology 18 (3), 819-832, 2016 | 60 | 2016 |
| Engineering a function into a glycosyltransferase C Krauth, M Fedoryshyn, C Schleberger, A Luzhetskyy, A Bechthold Chemistry & biology 16 (1), 28-35, 2009 | 51 | 2009 |
| A multidisciplinary approach toward identification of antibiotic scaffolds for Acinetobacter baumannii SP Bhamidimarri, M Zahn, JD Prajapati, C Schleberger, S Söderholm, ... Structure 27 (2), 268-280. e6, 2019 | 50 | 2019 |
| Structure and Action of a CC Bond Cleaving α/β-Hydrolase Involved in Nicotine Degration C Schleberger, P Sachelaru, R Brandsch, GE Schulz Journal of molecular biology 367 (2), 409-418, 2007 | 33 | 2007 |
| Binding structure of the leucine aminopeptidase inhibitor microginin FR1 M Kraft, C Schleberger, J Weckesser, GE Schulz FEBS letters 580 (30), 6943-6947, 2006 | 30 | 2006 |
| Getting Drugs through Small Pores: Exploiting the Porins Pathway in Pseudomonas aeruginosa S Samanta, I Bodrenko, S Acosta-Gutiérrez, T D’Agostino, M Pathania, ... ACS infectious diseases 4 (10), 1519-1528, 2018 | 27 | 2018 |
| Fragment‐Based Discovery of Non‐bisphosphonate Binders of Trypanosoma brucei Farnesyl Pyrophosphate Synthase L Münzker, JK Petrick, C Schleberger, D Clavel, I Cornaciu, R Wilcken, ... Chembiochem 21 (21), 3096-3111, 2020 | 10 | 2020 |
| Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β U Hommel, K Hurth, JM Rondeau, A Vulpetti, D Ostermeier, A Boettcher, ... Nature Communications 14 (1), 5497, 2023 | 2 | 2023 |
| A multidisciplinary approach towards identification of novel antibiotic scaffolds for Acinetobacter baumannii SP Bhamidimarri, M Zahn, JD Prajapati, C Schleberger, S Söderholm, ... bioRxiv, 306035, 2018 | 2 | 2018 |
| Investigating the human and nonobese diabetic mouse MHC class II immunopeptidome using protein language modeling P Hartout, B Počuča, C Méndez-García, C Schleberger Bioinformatics 39 (8), btad469, 2023 | | 2023 |
| Discovery of a selective and biologically active low-molecular weight antagonist of human IL-1b J Blank, A Blechschmidt, A Boettcher, F Bornancin, J Brady, J Eder, ... Nature communications 14, 5497-5509, 2023 | | 2023 |
| Pseudomonas aeruginosa in vivo Outer Membrane Proteome: Role of Simple Porins J BUYCK, P SAINT AUGUSTE, C SCHLEBERGER, D BUMANN Clinical Chemistry and Laboratory Medicine 54 (7), 2016 | | 2016 |
| Biologisch aktive Peptide aus Cyanobakterien-Eine wertvolle Quelle nicht-toxischer bioaktiver Substanzen J Weckesser, C Schleberger BIO Forum 32 (1), 20, 2009 | | 2009 |
| Fluorescent biosensors for antimicrobial screening Y Willer, NQ Le, C Hahn, C Schleberger, L Wilken, C Koenig, D Bumann, ... INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 298, 4-4, 2008 | | 2008 |
| Strukturanalyse des binären Toxins C2 aus Clostridium botulinum, von Protease-Inhibitor-Komplexen und der 2, 6-Dihydroxy-pseudo-oxynikotin-Hydrolase aus Arthrobacter … C Schleberger Freiburg (Breisgau), Univ., Diss., 2007, 2007 | | 2007 |
